Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Allam Fakhoury"'
Autor:
Fiona E. Watt, Nancy E Lane, Allam Fakhoury, Hélène Jacobs, Mary Beth Blauwet, Ronald A. Smulders
Publikováno v:
Osteoarthritis and cartilage, vol 27, iss 11
ObjectiveTo investigate the TrkA inhibitor, ASP7962, for treatment of painful knee osteoarthritis.DesignPhase 2a, double-blind, placebo- and naproxen-controlled, double-dummy, parallel-group study. Adults with knee osteoarthritis were randomized (2:2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1280b328692082932365edb91da09855
https://ora.ox.ac.uk/objects/uuid:ad26e7c0-bec8-4816-b4f7-9de9dc5caee6
https://ora.ox.ac.uk/objects/uuid:ad26e7c0-bec8-4816-b4f7-9de9dc5caee6
Publikováno v:
Pain Medicine: The Official Journal of the American Academy of Pain Medicine
Objective Evaluate the analgesic/antihyperalgesic effects of ASP9226, a state-dependent N-type voltage-gated calcium channel inhibitor, in healthy male subjects. Design Randomized, double-blind, double-dummy, placebo- and active comparator–controll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e830892373017eeecbe9a912f32de892
https://pubmed.ncbi.nlm.nih.gov/29378016
https://pubmed.ncbi.nlm.nih.gov/29378016
Autor:
Weizhong He, Steven A. Rosenberg, Allam Fakhoury, David H. Mitcheson, Victor W. Nitti, Nancy Martin
Publikováno v:
Journal of Urology. 190:1320-1327
Purpose: Bladder outlet obstruction often presents as storage and voiding symptoms. We investigated urodynamic parameters in men with lower urinary tract symptoms and bladder outlet obstruction treated with the β3 agonist mirabegron, a new therapy f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39dce97f3da58444defcb59c275646b0
https://doi.org/10.1016/j.juro.2013.05.062
https://doi.org/10.1016/j.juro.2013.05.062
Autor:
Steven A. Kaplan, William D. Koltun, Weizhong He, Allam Fakhoury, Tim Schneider, Jana Cummings
Publikováno v:
European Urology. 63:158-165
Background Alpha blockers are prescribed to manage lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Antimuscarinics are prescribed to treat overactive bladder (OAB). Objective To investigate the safety of a comb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa74937a51a264ccb68610ce5fca44f2
https://doi.org/10.1016/j.eururo.2012.07.003
https://doi.org/10.1016/j.eururo.2012.07.003
Autor:
Jason J. Luke, Geoffrey I. Shapiro, Allam Fakhoury, Takao Yamazaki, Carl Dmuchowski, Jeffrey R. Infante, Patricia LoRusso, Yukinori Arai, Andrew Krivoshik, Robin Schuster
Publikováno v:
Cancer chemotherapy and pharmacology. 77(3)
ASP9853 is an inhibitor of inducible nitric oxide (NO) synthase (iNOS) dimerization, which results in decreased NO production. Here, we report preclinical pharmacology of ASP9853 and the impact of ASP9853 in combination with a taxane on tumor volume
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48e260e8d5bdfb39a42885776488378f
https://pubmed.ncbi.nlm.nih.gov/26811179
https://pubmed.ncbi.nlm.nih.gov/26811179
Autor:
Marc R. Toglia, Donald R. Ostergard, Rodney A. Appell, Iqbal F. Hussain, Allam Fakhoury, Masakazu Andoh
Publikováno v:
International Urogynecology Journal. 21:847-854
VENUS evaluated the efficacy of solifenacin on urgency in patients with overactive bladder (OAB). We hypothesized that solifenacin would be comparably efficacious in continent and incontinent patients. VENUS was a 12-week, placebo-controlled trial in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70e4f2d88e71574500ac0832bf0e7c27
https://doi.org/10.1007/s00192-010-1120-6
https://doi.org/10.1007/s00192-010-1120-6
Autor:
Scott Serels, Masakazu Andoh, Mickey M. Karram, Allam Fakhoury, Marc R. Toglia, Sergio Forero-Schwanhaeuser
Publikováno v:
Urology. 73:14-18
Objectives In this double-blind, placebo-controlled trial, we assessed the efficacy and tolerability of solifenacin treatment for overactive bladder (OAB) with a focus on urgency-related endpoints. Changes in number of urgency episodes were evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14447d6639d6ce577f2d740ca2ab44e6
https://doi.org/10.1016/j.urology.2008.08.485
https://doi.org/10.1016/j.urology.2008.08.485
Autor:
Victor W, Nitti, Steven, Rosenberg, David H, Mitcheson, Weizhong, He, Allam, Fakhoury, Nancy E, Martin
Publikováno v:
The Journal of urology. 190(4)
Bladder outlet obstruction often presents as storage and voiding symptoms. We investigated urodynamic parameters in men with lower urinary tract symptoms and bladder outlet obstruction treated with the β₃ agonist mirabegron, a new therapy for over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5a49efdfcfffb1a8834dcc9646ef35e5
https://pubmed.ncbi.nlm.nih.gov/23727415
https://pubmed.ncbi.nlm.nih.gov/23727415
Publikováno v:
Journal of Urology. 189
VICTOR was a 12-week, double-blind, placebo controlled trial assessing the safety and tolerability of solifenacin plus tamsulosin in men with residual overactive bladder symptoms after tamsulosin monotherapy. Efficacy of solifenacin plus tamsulosin v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fea5022fdcf7b4762814e343d2a6a293
https://doi.org/10.1016/j.juro.2012.11.030
https://doi.org/10.1016/j.juro.2012.11.030
Autor:
Weizhong He, H. David Mitcheson, Steven A. Rosenberg, Victor W. Nitti, Nancy Martin, Allam Fakhoury
Publikováno v:
Journal of Urology. 187
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::461761402c4357567b6945dcd770e12e
https://doi.org/10.1016/j.juro.2012.02.2023
https://doi.org/10.1016/j.juro.2012.02.2023